Enbrel Myclic Pen Inj acquires commercialization approval

Pfizer Pharmaceuticals Korea(CEO/President Dong-Wook Oh) acquired commercialization approval for a pen-type administration of Enbrel(generic name: etanercept), a rheumatoid arthritis therapy, ‘Enbrel Myclic Pen Inj 50mg.’ Enbrel Myclic Pen allows patients to easily take injections with the auto-injector method.

Enbrel, the first disease-modifying antirheumatic drug(DMARD) approved in Korea, ha...